Coming back: autophagy in cachexia
- PMID: 24535215
- DOI: 10.1097/MCO.0000000000000048
Coming back: autophagy in cachexia
Abstract
Purpose of review: Cachexia is a complex syndrome characterized by body weight loss, tissue wasting, systemic inflammation, metabolic abnormalities, and altered nutritional status. One of the most prominent features of cachexia is the loss of muscle mass, mainly because of increased protein degradation rates. This review is aimed at discussing the involvement of autophagy in the pathogenesis of muscle wasting in cachexia.
Recent findings: Modulations of muscle mass in the adult reflect an imbalance between protein synthesis and degradation rates. Muscle depletion in cachexia is associated with increased protein breakdown, mainly involving the pathways dependent on ubiquitin-proteasome and autophagy-lysosomes. This latter, in particular, was considered not relevant for a long time. Just in the last years, autophagy was shown to contribute to the pathogenesis of muscle wasting not only in myopathies because of intrinsic muscle defects, but also in muscle depletion associated with conditions such as sepsis, chronic obstructive pulmonary disease, glucocorticoid treatment, cancer cachexia, and aging.
Summary: The present review highlights that both excess and defective autophagy are relevant to the onset of muscle depletion, and draws some considerations about possible therapeutic intervention aimed at modulating autophagy in order to improve muscle trophism.
Video abstract: http://links.lww.com/COCN/A5.
Similar articles
-
Systemic inflammation in chronic obstructive pulmonary disease and lung cancer: common driver of pulmonary cachexia?Curr Opin Support Palliat Care. 2014 Dec;8(4):339-45. doi: 10.1097/SPC.0000000000000088. Curr Opin Support Palliat Care. 2014. PMID: 25158627 Review.
-
Autophagic degradation contributes to muscle wasting in cancer cachexia.Am J Pathol. 2013 Apr;182(4):1367-78. doi: 10.1016/j.ajpath.2012.12.023. Epub 2013 Feb 8. Am J Pathol. 2013. PMID: 23395093
-
Muscle wasting in cancer: the role of mitochondria.Curr Opin Clin Nutr Metab Care. 2015 May;18(3):221-5. doi: 10.1097/MCO.0000000000000164. Curr Opin Clin Nutr Metab Care. 2015. PMID: 25769061 Review.
-
[Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)].Nutr Hosp. 2006 May;21 Suppl 3:38-45. Nutr Hosp. 2006. PMID: 16768029 Review. Spanish.
-
Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.Int J Cancer. 2010 Feb 1;126(3):756-63. doi: 10.1002/ijc.24784. Int J Cancer. 2010. PMID: 19634137
Cited by
-
Molecular Mechanisms of Cachexia: A Review.Cells. 2024 Jan 29;13(3):252. doi: 10.3390/cells13030252. Cells. 2024. PMID: 38334644 Free PMC article. Review.
-
Highlighting the idea of exerkines in the management of cancer patients with cachexia: novel insights and a critical review.BMC Cancer. 2023 Sep 20;23(1):889. doi: 10.1186/s12885-023-11391-3. BMC Cancer. 2023. PMID: 37730552 Free PMC article. Review.
-
Redox Signaling in Chronic Kidney Disease-Associated Cachexia.Antioxidants (Basel). 2023 Apr 18;12(4):945. doi: 10.3390/antiox12040945. Antioxidants (Basel). 2023. PMID: 37107320 Free PMC article. Review.
-
Modelling Cancer Metastasis in Drosophila melanogaster.Cells. 2023 Feb 21;12(5):677. doi: 10.3390/cells12050677. Cells. 2023. PMID: 36899813 Free PMC article. Review.
-
Amino Acids in Cancer and Cachexia: An Integrated View.Cancers (Basel). 2022 Nov 19;14(22):5691. doi: 10.3390/cancers14225691. Cancers (Basel). 2022. PMID: 36428783 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials

